CSL Limited (CSLLY)
(Delayed Data from OTC)
$99.58 USD
-1.18 (-1.17%)
Updated Sep 20, 2024 03:59 PM ET
4-Sell of 5 4
C Value B Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.57 | 1.38 | 9.99 |
Current Quarter Estimate | NA | 3.11 | 61.00 |
Year Ago Quarter Estimate | NA | -4.81 | 54.84 |
Next Quarter Estimate | NA | 3.91 | 63.00 |
Next Year Estimate | 4.03 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 13.62 | 17.30 | 15.67 |
Next Year | 17.84 | 9.90 | 11.34 |
Last 5 Years | 7.30 | 0.90 | 8.10 |
Next 5 Years | 14.70 | 21.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.90 |
Price/Book (MRQ) | 4.96 | 2.10 |
Price/Cash Flow (MRFY) | 25.03 | 16.43 |
Dividend Yield | 1.36% | 0.00% |
Net Profit Margin (TTM) | NA | -150.51% |
Return on Equity (TTM) | NA | -61.16% |
Debt to Equity (MRQ) | 0.58 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.